X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
75
PharmaCompass offers a list of Hyoscine Butyl Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hyoscine Butyl Bromide manufacturer or Hyoscine Butyl Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hyoscine Butyl Bromide manufacturer or Hyoscine Butyl Bromide supplier.
PharmaCompass also assists you with knowing the Hyoscine Butyl Bromide API Price utilized in the formulation of products. Hyoscine Butyl Bromide API Price is not always fixed or binding as the Hyoscine Butyl Bromide Price is obtained through a variety of data sources. The Hyoscine Butyl Bromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Butylscopolamine Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butylscopolamine Bromide, including repackagers and relabelers. The FDA regulates Butylscopolamine Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butylscopolamine Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Butylscopolamine Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Butylscopolamine Bromide supplier is an individual or a company that provides Butylscopolamine Bromide active pharmaceutical ingredient (API) or Butylscopolamine Bromide finished formulations upon request. The Butylscopolamine Bromide suppliers may include Butylscopolamine Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Butylscopolamine Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Butylscopolamine Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Butylscopolamine Bromide active pharmaceutical ingredient (API) in detail. Different forms of Butylscopolamine Bromide DMFs exist exist since differing nations have different regulations, such as Butylscopolamine Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Butylscopolamine Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Butylscopolamine Bromide USDMF includes data on Butylscopolamine Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Butylscopolamine Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Butylscopolamine Bromide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Butylscopolamine Bromide Drug Master File in Japan (Butylscopolamine Bromide JDMF) empowers Butylscopolamine Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Butylscopolamine Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Butylscopolamine Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Butylscopolamine Bromide suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Butylscopolamine Bromide Drug Master File in Korea (Butylscopolamine Bromide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Butylscopolamine Bromide. The MFDS reviews the Butylscopolamine Bromide KDMF as part of the drug registration process and uses the information provided in the Butylscopolamine Bromide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Butylscopolamine Bromide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Butylscopolamine Bromide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Butylscopolamine Bromide suppliers with KDMF on PharmaCompass.
A Butylscopolamine Bromide CEP of the European Pharmacopoeia monograph is often referred to as a Butylscopolamine Bromide Certificate of Suitability (COS). The purpose of a Butylscopolamine Bromide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Butylscopolamine Bromide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Butylscopolamine Bromide to their clients by showing that a Butylscopolamine Bromide CEP has been issued for it. The manufacturer submits a Butylscopolamine Bromide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Butylscopolamine Bromide CEP holder for the record. Additionally, the data presented in the Butylscopolamine Bromide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Butylscopolamine Bromide DMF.
A Butylscopolamine Bromide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Butylscopolamine Bromide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Butylscopolamine Bromide suppliers with CEP (COS) on PharmaCompass.
A Butylscopolamine Bromide written confirmation (Butylscopolamine Bromide WC) is an official document issued by a regulatory agency to a Butylscopolamine Bromide manufacturer, verifying that the manufacturing facility of a Butylscopolamine Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Butylscopolamine Bromide APIs or Butylscopolamine Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Butylscopolamine Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Butylscopolamine Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Butylscopolamine Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Butylscopolamine Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Butylscopolamine Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Butylscopolamine Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Butylscopolamine Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Butylscopolamine Bromide suppliers with NDC on PharmaCompass.
Butylscopolamine Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butylscopolamine Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butylscopolamine Bromide GMP manufacturer or Butylscopolamine Bromide GMP API supplier for your needs.
A Butylscopolamine Bromide CoA (Certificate of Analysis) is a formal document that attests to Butylscopolamine Bromide's compliance with Butylscopolamine Bromide specifications and serves as a tool for batch-level quality control.
Butylscopolamine Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Butylscopolamine Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butylscopolamine Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Butylscopolamine Bromide EP), Butylscopolamine Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butylscopolamine Bromide USP).
Market Place
